Sort   by:  
 Page size 
UnknownTipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naive HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.
Not available
S-EPMC4701182 | biostudies-literature
UnknownThe potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT).
Not available
S-EPMC5487698 | biostudies-literature
UnknownDesign, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74.
Not available
S-EPMC8000227 | biostudies-literature
UnknownGenetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.
Not available
S-EPMC3431328 | biostudies-literature
UnknownThe Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Not available
S-EPMC9447373 | biostudies-literature
UnknownToward discovery science of human brain function.
Not available
S-EPMC2842060 | biostudies-literature
UnknownExpanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders.
Not available
S-EPMC11739428 | biostudies-literature
UnknownSchizophrenia risk from complex variation of complement component 4.
Not available
S-EPMC4752392 | biostudies-literature
UnknownHippocampal Formation Maldevelopment and Sudden Unexpected Death across the Pediatric Age Spectrum.
Not available
S-EPMC6281079 | biostudies-literature
UnknownResponses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Not available
S-EPMC9334931 | biostudies-literature
Sort   by:  
 Page size